High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study, Arthritis & Rheumatism, vol.52, issue.Suppl, pp.1060-1068, 2010. ,
DOI : 10.1111/j.1445-5994.1987.tb01232.x
DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT, Australian and New Zealand Journal of Medicine, vol.32, issue.3, pp.301-305, 1987. ,
DOI : 10.1002/j.1552-4604.1975.tb01465.x
Colchicine for acute gout, Cochrane Database Syst Rev, vol.65, issue.4, p.6190, 2014. ,
DOI : 10.1002/14651858.CD006190
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT), Annals of the Rheumatic Diseases, vol.65, issue.10, pp.1312-1336, 2006. ,
DOI : 10.1136/ard.2006.055269
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis, Arthritis Care & Research, vol.64, issue.Suppl, pp.1447-61, 2012. ,
DOI : 10.1002/art.33483
Patient and provider barriers to effective management of gout in general practice: a qualitative study: Figure 1, Annals of the Rheumatic Diseases, vol.71, issue.9, pp.1490-1495, 2012. ,
DOI : 10.1136/annrheumdis-2011-200801
Gout: why is this curable disease so seldom cured?, Annals of the Rheumatic Diseases, vol.71, issue.11, pp.1765-70, 2012. ,
DOI : 10.1136/annrheumdis-2012-201687
Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire, Rheumatology, vol.52, issue.9, pp.1623-1632, 2013. ,
DOI : 10.1093/rheumatology/ket158
Gout: from international guidelines to current practice. Results from a physician questionnaire, Clinical Rheumatology, vol.52, issue.11, pp.1693-1697, 2013. ,
DOI : 10.1093/rheumatology/ket215
Colchicine-Induced Rhabdomyolysis, Annals of Pharmacotherapy, vol.18, issue.5, pp.824-830, 2002. ,
DOI : 10.1097/00000441-197603000-00014
Accidental colchicine overdose. A case report and literature review, Emergency Medicine Journal, vol.19, issue.3, pp.265-272, 2002. ,
DOI : 10.1136/emj.19.3.265
Unsuspected colchicine overdose in a female patient presenting as an acute abdomen, Anaesth Intensive Care, vol.35, pp.437-446, 2007. ,
Colchicine poisoning: the dark side of an ancient drug, Clinical Toxicology, vol.255, issue.5, pp.407-421, 2010. ,
DOI : 10.1016/0300-483X(91)90015-S
Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors, Arthritis & Rheumatism, vol.38, issue.8, pp.2226-2263, 2011. ,
DOI : 10.1016/j.semarthrit.2008.08.006
Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review, Seminars in Arthritis and Rheumatism, vol.42, issue.2, pp.166-78, 2012. ,
DOI : 10.1016/j.semarthrit.2012.03.013
GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n=1003), Joint Bone Spine, vol.79, issue.5, pp.464-70, 2012. ,
DOI : 10.1016/j.jbspin.2011.12.006
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney International, vol.67, issue.6, pp.2089-100, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00365.x
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report, Kidney International, vol.80, issue.1, pp.17-28, 2011. ,
DOI : 10.1038/ki.2010.483
SAT0531???Updated Eular Evidence-Based Recommendations for the Management of Gout, Annals of the Rheumatic Diseases, vol.73, issue.Suppl 2, pp.783-783, 2014. ,
DOI : 10.1136/annrheumdis-2014-eular.5022
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout, Rheumatology, vol.46, issue.8, pp.1372-1376, 2007. ,
DOI : 10.1093/rheumatology/kem056a
Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout, J Rheumatol, vol.18, pp.264-273, 1991. ,
Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study, American Journal of Kidney Diseases, vol.55, issue.4, pp.648-59, 2010. ,
DOI : 10.1053/j.ajkd.2009.12.016
A New Equation to Estimate Glomerular Filtration Rate, Annals of Internal Medicine, vol.150, issue.9, pp.604-616, 2009. ,
DOI : 10.7326/0003-4819-150-9-200905050-00006
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005, Annals of the Rheumatic Diseases, vol.67, issue.7, pp.960-966, 2000. ,
DOI : 10.1136/ard.2007.076232
Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR), Arthritis Research & Therapy, vol.15, issue.5, p.101, 2013. ,
DOI : 10.3899/jrheum.080506
Rhabdomyolysis in a Patient Treated with Colchicine and Atorvastatin, Annals of Pharmacotherapy, vol.156, issue.7-8, pp.1466-1475, 2006. ,
DOI : 10.1016/j.toxlet.2004.12.008
Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine, Annals of Pharmacotherapy, vol.18, issue.7-8, pp.1358-61, 2005. ,
DOI : 10.1592/phco.24.17.1784.52334